Two Sigma Investments’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Two Sigma Investments’s Portfolio OPNT Stock Details OPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-21,730	Closed	-$234K	–	3190
2022 Q3	$234K	Sell	21,730 -15,326	-41%	-$174K	﹤0.01%	2052
2022 Q2	$444K	Sell	37,056 -1,776	-5%	-$28.6K	﹤0.01%	1873
2022 Q1	$832K	Sell	38,832 -25,225	-39%	-$668K	﹤0.01%	1793
2021 Q4	$2.15M	Buy	64,057 +13,012	+25%	+$363K	﹤0.01%	1854
2021 Q3	$1.31M	Buy	+51,045	New	+$912K	﹤0.01%	2366

Other funds holding OPNT

WSL

Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return

ACA

Apis Capital Advisors New York $648M AUM 302.67% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

NYLIM

New York Life Investment Management New York $11.8B AUM 23.45% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Ramius Advisors New York $95.2M AUM 7.33% 1-Year Est. Return

Two Sigma Investments's OPNT Position: Q4 2022 in Review

Two Sigma Investments sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q4 2022, closing a stake of 21,730 shares — an estimated $234K sold.

Two Sigma Investments first reported a position in OPNT in Q3 2021 and held it in 5 quarters. The position peaked at $2.15M in Q4 2021. 37 funds tracked by Wall St. Rank hold OPNT as of Q4 2022.

Two Sigma Investments reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Two Sigma Investments sold 21,730 Opiant Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $234K.
Two Sigma Investments first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q3 2021 and held it in 5 quarters.
Two Sigma Investments's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $2.15M in Q4 2021.
37 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on Two Sigma Investments's 13F filing for Q4 2022, filed 14 Feb 2023.